May 24, 2017 13:12 pm UTC| Business
OXNARD, Calif., May 24, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that it has received...
Launch of a Project using Artificial Intelligence (AI) to Improve Customer Satisfaction
May 24, 2017 13:12 pm UTC| Business
TOKYO, May 24, 2017 -- Sumitomo Mitsui Financial Group, Inc. (SMFG) (President and Group Chief Executive Officer: Takeshi Kunibe) and SMBC Nikko Securities Inc. (President CEO: Yoshihiko Shimizu) have assessed and...
Launch of a Project using Artificial Intelligence (AI) to Improve Customer Satisfaction
May 24, 2017 13:12 pm UTC| Business
TOKYO, May 24, 2017 -- Sumitomo Mitsui Financial Group, Inc. (SMFG) (President and Group Chief Executive Officer: Takeshi Kunibe) and SMBC Nikko Securities Inc. (President CEO: Yoshihiko Shimizu) have assessed and...
Launch of a Project using Artificial Intelligence (AI) to Improve Customer Satisfaction
May 24, 2017 13:12 pm UTC| Business
TOKYO, May 24, 2017 -- Sumitomo Mitsui Financial Group, Inc. (SMFG) (President and Group Chief Executive Officer: Takeshi Kunibe) and SMBC Nikko Securities Inc. (President CEO: Yoshihiko Shimizu) have assessed and...
Launch of a Project using Artificial Intelligence (AI) to Improve Customer Satisfaction
May 24, 2017 13:12 pm UTC| Business
TOKYO, May 24, 2017 -- Sumitomo Mitsui Financial Group, Inc. (SMFG) (President and Group Chief Executive Officer: Takeshi Kunibe) and SMBC Nikko Securities Inc. (President CEO: Yoshihiko Shimizu) have assessed and...
May 24, 2017 13:11 pm UTC| Business
OXNARD, Calif., May 24, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that it has received...
May 24, 2017 13:11 pm UTC| Business
OXNARD, Calif., May 24, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that it has received...